Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHS-0214 vs Enbrel in Chronic Plaque Psoriasis
NCT02134210Phase 3Completed
- Sponsor
- Coherus BioSciences, Inc.
- Start
- Jun 2014
- Primary completion
- Jul 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 7
01
Overview
A Phase 3 trial of GP2015 in plaque psoriasis, sponsored by Coherus BioSciences, Inc.. Started Jun 2014; status: completed.
02
Drugs
GP2015
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02134210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134210.